High Prevalence of Hepatitis and Increasing Awareness Regarding Hepatitis to Augment Growth of Hepatitis Drugs Market

Hepatitis Drugs Market

 High prevalence of hepatitis is expected to propel growth of the global hepatitis drugs market. For instance, in May 2019, according to the study, ‘Prevalence of hepatitis B surface antigen (HBsAg) positivity and its associated factors in Rwanda’, published in May 2019, in BMC Infectious Diseases, the prevalence of hepatitis B surface antigen was 3.9% in the study population. Moreover, development of novel diagnostic tests is also expected to aid in growth of the market. For instance, in January 2019, LabCorp, along with its subsidiary Covance Inc., partnered with GENFIT, a biopharmaceutical company focused on R&D in liver diseases, for access to non-alcoholic steatohepatitis liver diagnostic test for the clinical research market.

Increasing awareness regarding hepatitis is expected to offer lucrative growth opportunities for players in the global hepatitis drugs market. For instance, in May 2020, Echosens, a provider of non-invasive diagnostic products and services for liver diagnosis, urged increased vigilance around liver health during May 2020 Hepatitis Awareness Month. Moreover, R&D in new therapies is also expected to aid in growth of the market. For instance, in December 2020, Aligos Therapeutics, Inc. entered into an Exclusive License and Research Collaboration Agreement with Merck, under which Merck and Aligos will apply Aligos’ oligonucleotide platform technology to discover, research, optimize and develop oligonucleotides directed against a non-alcoholic steatohepatitis (NASH) target and up to one additional target of interest in the cardiometabolic/fibrosis space.

Competitive Analysis

Major players operating in the global hepatitis drugs market include, Merck & Co. Inc., Gilead Sciences Inc., AbbVie Inc., Bristol Myers Squibb Company, Gilead Sciences, F. Hoffmann-La Roche Ltd., LAURUS Labs, Zydus Cadila, Hetero Healthcare Limited, GlaxoSmithKline PLC., and Cipla Inc.

Major players operating in the global hepatitis drugs market are focused on adopting M&A strategies to enhance their market share. For instance, in December 2020, Gilead Sciences signed a definitive agreement to acquire German biotechnology company MYR for approximately US$ 1.4 billion in cash. With this deal, Gilead will acquire First-in-Class entry inhibitor Hepcludex (bulevirtide) for the treatment of chronic hepatitis delta virus (HDV), a severe form of viral hepatitis.

Major players operating in the global hepatitis drugs market are also focused on adopting collaboration strategies to enhance their market share. For instance, in January 2021, Gilead Sciences, Inc. collaborated with Vir Biotechnology, Inc. to evaluate therapeutic combination strategies aimed at developing a functional cure for chronic hepatitis B virus.

Location: India

Comments

Post a Comment

Popular posts from this blog

Fitness Equipment Market is doing warm-ups to pull growth-rich opportunities from the growing obesity rates accompanied by the sedentary lifestyles

Image
  Fitness equipment is any mechanical device or equipment used in sport or exercise to improve the physical performance or strength of that activity by providing either adjustable or constant levels of force, either of dynamic nature that is immediately available to exert (such as running) or of a static type that requires adjustments (such as a bicycle). Some common types of equipment are treadmills, elliptical machines, step machines, exercise bicycles, recumbent bikes, treadmill monitors, rowing machines, and many more. Fitness equipment is used in gyms and private home fitness facilities as well as public parks and recreational facilities. Fitness equipment for the home is designed to provide low-impact aerobic workouts. Some items are available for rent or sale on the Internet. Rowing machines and exercise bicycles can give an all-over body workout, while Schwinn exercise bicycles can be used to target specific muscles. Fitness equipment for home gyms can be classified into card
Read more

The market for ureteral stents would benefit from the rising prevalence of urological diseases

Image
  A ureteral stent is a slender adaptable cylinder embedded straightforwardly into the ureter to forestall or cure block of the urinary entry from the ureter. The length of these stents utilized for grown-up quiet's reaches somewhere in the range of 30 and 24 inches. Furthermore, various distances across or sizes of stents are accessible, to suit distinctive ureter sizes. This permits treatment choices to be customized to the person, just as to the degree of obstacle. Urinary stents are made of either metal silicone or plastic. They are set straightforwardly into the bladder through the urethra valve. Ureteral stents can either be made percutaneously, through medical procedure or by methods for an outpatient strategy. Contingent upon the sort of ureter that is influenced, the technique can be either a solitary needle or numerous needles. The developing commonness of urological illnesses around the world is driving the development of the ureteral stents market . Development in t
Read more

The North America Vision Care Market Is Driven by the Increasing Prevalence of Eye Diseases in this Region

Image
  Vision care refers to the prevention and treatment of various eye conditions or eye diseases, such as refractive errors, age-related macular degeneration, cataract, glaucoma, etc. Vision care helps prevent or minimize the threat to eyes or visual integrity. Therefore, in North America, demand for vision care is has increased due the increasing prevalence of eye diseases, driving the North America vision care market growth. According to the Centers for Disease Control and Prevention (CDC), cataract affects around 24.4 million Americans (aged 40 and older) or around one in every six people in this age group. Vision care is important because 80% of what we perceive comes through our sense of sight. By protecting the eyes, people can reduce the odds of vision loss or blindness while also staying on top of any developing eye diseases such as glaucoma and cataracts. Vision care products used for restoration of eye sights include contact lenses, reading glasses, frames, Rx-Lenses, non Rx-
Read more